In this study, we report for the first time that repeated administration of serum EVs from young mice to aged mice improved aged‐related fibrosis, increased locomotion, and whole‐body insulin sensitivity by increasing p‐Akt levels in the skeletal muscle. Here, AKT1 is linked to fibrosis.